News

Published on 9 Nov 2023 on Insider Monkey via Yahoo Finance

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript


Article preview image

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript November 8, 2023

Operator: Welcome to the Fate Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are mode. The call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com. As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, Present and CEO of Fate Therapeutics.

Scott Wolchko: Thank you. Good afternoon and thanks everyone for joining us for the Fate Therapeutics third quarter 2023 financial results call. Shortly after 4:00 p.m. Eastern Time today, we issued a press release with these results, which can be found on the Investors section of our website under Press Releases. In addition, our Form 10-Q for the quarter ended September 30, 2023, was filed shortly thereafter and can be found on the Investors section of our website under Financial Information. Before we begin, I'd like to remind everyone that except for statements of historical facts, the statements made by management and responses to questions on this conference call are forward-looking statements under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

NASDAQ.FATE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript February 26, 2024 Fate The...

Insider Monkey via Yahoo Finance 1 Mar 2024

Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price...

It's been a good week for Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders, because the company...

Simply Wall St. via Yahoo Finance 29 Feb 2024

Fate Therapeutics (FATE) Q4 Earnings Beat, Revenues Fall Y/Y

Fate Therapeutics FATE reported fourth-quarter 2023 loss of 45 cents per share, narrower than the...

Zacks via Yahoo Finance 27 Feb 2024

Domino's To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Agree Realty...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 27 Feb 2024

Fate Therapeutics Insiders US$207k Short Of Breakeven On Stock Purchase

Insiders who bought US$698.1k worth of Fate Therapeutics, Inc. (NASDAQ:FATE) stock in the last ye...

Simply Wall St. via Yahoo Finance 29 Dec 2023

FATE Q3 Earnings Beat on Lower Expenses, Revenues Fall Y/Y

Fate Therapeutics FATE reported a loss of 46 cents per share in the third quarter of 2023, narrow...

Zacks via Yahoo Finance 9 Nov 2023

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript November 8, 2023 Operator:...

Insider Monkey via Yahoo Finance 9 Nov 2023

FATE Q2 Earnings Beat on Lower Expenses, Revenues Miss

Fate Therapeutics FATE reported a loss of 54 cents per share in the second quarter of 2023, narro...

Zacks via Yahoo Finance 9 Aug 2023

One Fate Therapeutics Insider Raised Stake By 83% In Previous Year

Viewing insider transactions for Fate Therapeutics, Inc.'s (NASDAQ:FATE ) over the last year, we ...

Simply Wall St. via Yahoo Finance 22 Jul 2023

Fate Therapeutics, Inc.'s (NASDAQ:FATE) Low P/S No Reason For Excitement

Fate Therapeutics, Inc.'s (NASDAQ:FATE) price-to-sales (or "P/S") ratio of 3.8x might make it loo...

Simply Wall St. via Yahoo Finance 4 Jun 2023